More on TVTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.3 Score)

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Travere Therapeutics (NQ:TVTX)
Delayed: 27.24 -0.07 (0.26%)
Prev. Close $27.31  
Open$26.61 
52 Wk High$ 
52 Wk Low$ 
Day High$27.40 
Day Low$26.43 
P/E N/A  
EPS$ 
Volume1,433,538 

Friends, Peers and Foes (?): CSL, CSLLY, ESPR, VRCA, ACLX (more...)

Feb 24, 2026 04:06 PM Form 4 Travere Therapeutics, For: Feb 20 Filed by: Dube Eric M
Feb 20, 2026 04:49 PM Form 144 Travere Therapeutics, Filed by: Dube Eric M
Feb 20, 2026 02:11 PM Travere Therapeutics (TVTX) PT Raised to $45 at TD Cowen
Feb 19, 2026 04:48 PM Form 10-K Travere Therapeutics, For: Dec 31
Feb 19, 2026 04:34 PM Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss
Feb 19, 2026 04:10 PM Form 4 Travere Therapeutics, For: Feb 17 Filed by: REED ELIZABETH E
Feb 19, 2026 04:06 PM Form 8-K Travere Therapeutics, For: Feb 19
Feb 19, 2026 04:01 PM Travere Therapeutics (TVTX) Tops Q4 EPS by 41c
Feb 19, 2026 04:01 PM Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 17, 2026 09:38 PM Form SCHEDULE 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
View All Articles

Entities mentioned with TVTX

View All Entities